Invesaro

Stocks Comparison

agilon health vs NewGenIvf: revenue, profit, margins and growth compared

agilon health brought in $5.9B of revenue in fiscal 2025, NewGenIvf $23.7M in fiscal 2025. Revenue changed by -2.1% at agilon health and +336.3% at NewGenIvf on the year before, so NewGenIvf grew faster. agilon health kept -6.6% of its revenue as net profit, NewGenIvf 41.7%. Free cash flow was -$119M at agilon health and -$11.1M at NewGenIvf.

Side by side, latest fiscal year

AGLNIVF
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$5.9B$23.7M
Revenue growth-2.1%+336.3%
Net income-$391.3M$9.9M
Net margin-6.6%41.7%
Free cash flow-$119M-$11.1M
Free cash flow margin-2.0%-46.7%
Earnings per share (diluted)n/a$3.04
Cash$173.7M$758.6K
Debt$35Mn/a
Price to earningsn/an/a
Market value$1.4B$3.3M
Dividend yieldn/an/a
Rank by revenue in sector#58 of 646 · Health care#425 of 646 · Health care

Over the years

Revenue
AGL FY2019: $794.4MAGL FY2021: $1.2BAGL FY2021: $1.5BAGL FY2022: $2.4BAGL FY2023: $4.3BAGL FY2024: $6.1BAGL FY2025: $5.9BNIVF FY2021: $4.1MNIVF FY2023: $5.9MNIVF FY2023: $5.1MNIVF FY2024: $5.4MNIVF FY2025: $23.7MFY19FY21FY22FY23FY24FY25
AGL $5.9BNIVF $23.7M
Net income
AGL FY2019: -$282.6MAGL FY2021: -$60.1MAGL FY2021: -$406.5MAGL FY2022: -$106.6MAGL FY2023: -$262.6MAGL FY2024: -$260.2MAGL FY2025: -$391.3MNIVF FY2021: -$533NIVF FY2023: $458.7KNIVF FY2023: $130.2KNIVF FY2024: -$524.6KNIVF FY2025: $9.9MFY19FY21FY22FY23FY24FY25
AGL -$391.3MNIVF $9.9M
Net margin
AGL FY2019: -35.6%AGL FY2021: -4.9%AGL FY2021: -26.7%AGL FY2022: -4.5%AGL FY2023: -6.1%AGL FY2024: -4.3%AGL FY2025: -6.6%NIVF FY2021: -0.0%NIVF FY2023: 7.7%NIVF FY2023: 2.5%NIVF FY2024: -9.7%NIVF FY2025: 41.7%FY19FY21FY22FY23FY24FY25
AGL -6.6%NIVF 41.7%
Revenue growth
AGL FY2021: +53.4%AGL FY2021: +24.9%AGL FY2022: +57.0%AGL FY2023: +80.7%AGL FY2024: +40.4%AGL FY2025: -2.1%NIVF FY2023: +44.3%NIVF FY2023: -13.6%NIVF FY2024: +5.8%NIVF FY2025: +336.3%FY21FY22FY23FY24FY25
AGL -2.1%NIVF +336.3%
Free cash flow
AGL FY2019: -$106.8MAGL FY2021: -$55MAGL FY2021: -$154.7MAGL FY2022: -$146.2MAGL FY2023: -$172MAGL FY2024: -$71MAGL FY2025: -$119MNIVF FY2021: $1.4MNIVF FY2023: $1.6MNIVF FY2023: -$1.8MNIVF FY2024: -$8.3MNIVF FY2025: -$11.1MFY19FY21FY22FY23FY24FY25
AGL -$119MNIVF -$11.1M

Fiscal years as each company reports them; the two may end in different months.

Questions about agilon health and NewGenIvf

Which is bigger by revenue, agilon health or NewGenIvf?

agilon health is bigger by revenue: $5.9B in fiscal 2025, against $23.7M for NewGenIvf in fiscal 2025.

Which keeps more of its revenue as profit, agilon health or NewGenIvf?

agilon health had a net margin of -6.6% in fiscal 2025; NewGenIvf had 41.7% in fiscal 2025.

Which grew revenue faster, agilon health or NewGenIvf?

In their latest fiscal years revenue changed by -2.1% at agilon health and +336.3% at NewGenIvf.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies